Lateral lymph node dissection for low rectal cancer: Is it necessary?


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
21 Aug 2019
Historique:
received: 05 05 2019
revised: 19 06 2019
accepted: 19 07 2019
entrez: 10 9 2019
pubmed: 10 9 2019
medline: 15 2 2020
Statut: ppublish

Résumé

Rectal cancer constitutes a major public health issue. Total mesorectal excision has remained the gold standard treatment for mid and low rectal tumors since its introduction in the late 1980s. Removal of all lymph nodes located in the mesorectum has indeed improved pathological and oncological outcomes. However, when cancer spreads to the lateral lymph nodes (located along the iliac and obturator arteries) Western and Japanese practices differ. Where the Western guidelines consider this condition as an advanced form of the disease and use neoadjuvant radiochemotherapy liberally, the Japanese guidelines define it as a local disease and proceed to lateral lymph node dissection with or without neoadjuvant treatment. Herein, we review the current literature regarding both therapeutic strategies, with the aim of contributing to potential improvements in treatment and outcome for patients with low and mid rectal cancer.

Identifiants

pubmed: 31496614
doi: 10.3748/wjg.v25.i31.4294
pmc: PMC6710187
doi:

Types de publication

Editorial Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4294-4299

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare no conflicts of interest.

Références

J Natl Cancer Inst. 2001 Apr 18;93(8):583-96
pubmed: 11309435
Dis Colon Rectum. 2002 Feb;45(2):200-6
pubmed: 11852333
Dis Colon Rectum. 2003 Mar;46(3):333-9
pubmed: 12626908
Dis Colon Rectum. 1959 Mar-Apr;2(2):169-72
pubmed: 13652786
J Clin Oncol. 2005 Mar 20;23(9):1847-58
pubmed: 15774778
Med Sci Monit. 2006 Feb;12(2):CR70-4
pubmed: 16449950
Br J Surg. 2006 Dec;93(12):1519-25
pubmed: 17054311
Br J Surg. 2007 Aug;94(8):1014-9
pubmed: 17436337
Ann Surg Oncol. 2008 Mar;15(3):729-37
pubmed: 18057989
Langenbecks Arch Surg. 2008 Mar;393(2):173-80
pubmed: 18172677
Dis Colon Rectum. 2009 Apr;52(4):567-76
pubmed: 19404054
Lancet Oncol. 2009 Nov;10(11):1053-62
pubmed: 19767239
Arch Surg. 2011 May;146(5):540-3
pubmed: 21576608
Langenbecks Arch Surg. 2012 Mar;397(3):353-61
pubmed: 22105772
Ann Surg. 2012 Jun;255(6):1129-34
pubmed: 22549752
Lancet Oncol. 2012 Jun;13(6):616-21
pubmed: 22591948
Br J Hosp Med (Lond). 2013 Jul;74(7):377-80
pubmed: 24159637
Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34
pubmed: 24183379
J Am Coll Surg. 2014 May;218(5):969-977.e1
pubmed: 24661852
Anticancer Res. 2015 May;35(5):2849-56
pubmed: 25964566
J Clin Oncol. 2016 Jun 20;34(18):2157-64
pubmed: 27138577
Med Image Anal. 2016 Oct;33:170-175
pubmed: 27423409
World J Surg. 2017 Mar;41(3):876-883
pubmed: 27730348
Ann Surg. 2017 Aug;266(2):201-207
pubmed: 28288057
Int J Clin Oncol. 2018 Feb;23(1):1-34
pubmed: 28349281
Eur J Surg Oncol. 2018 Apr;44(4):463-468
pubmed: 29428473
Ann Surg Oncol. 2018 Jun;25(6):1454-1455
pubmed: 29616422
Am J Surg Pathol. 2018 Jun;42(6):705-714
pubmed: 29624511
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Clin Oncol. 2019 Jan;24(1):46-52
pubmed: 30259217
J Clin Oncol. 2019 Jan 1;37(1):33-43
pubmed: 30403572
BJS Open. 2018 Jul 27;2(6):433-451
pubmed: 30511044
Jpn J Clin Oncol. 1984 Dec;14(4):623-32
pubmed: 6520971
Jpn J Surg. 1983 Nov;13(6):574-98
pubmed: 6672391
Br J Surg. 1982 Oct;69(10):613-6
pubmed: 6751457
Eur J Cancer. 1995 Jul-Aug;31A(7-8):1229-32
pubmed: 7577028
Br J Surg. 1996 Feb;83(2):214-6
pubmed: 8689166
Arch Surg. 1998 Aug;133(8):894-9
pubmed: 9711965

Auteurs

Niki Christou (N)

Service de Chirurgie Digestive, Endocrinienne et Générale, CHU de Limoges, Limoges Cedex 87042, France.

Jeremy Meyer (J)

Division of Digestive Surgery, University Hospitals of Geneva, Genève 1211, Switzerland.

Christian Toso (C)

Division of Digestive Surgery, University Hospitals of Geneva, Genève 1211, Switzerland.

Frédéric Ris (F)

Division of Digestive Surgery, University Hospitals of Geneva, Genève 1211, Switzerland.

Nicolas Christian Buchs (NC)

Division of Digestive Surgery, University Hospitals of Geneva, Genève 1211, Switzerland, christou.niki19@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH